Nalu
Carlsbad, US · 216 employees on LinkedIn · 8 known investors
Find your way into Nalu
803 people in our graph share verified history with the Nalu team — schools, employers, funds. One of them is your warm intro.
Teresa Chanunlockedknows Thomas A. West · together at Johnson & Johnson (overlapped)
×3knows the team · via Johnson & Johnson
×2knows the team · via Princeton University
×3knows the team · via The Wharton School
×2knows the team · via University of Calgary
knows the team · via Michigan State University - Eli Broad College of Business
Nalu Medical develops a non-integrated neurostimulation system that uses electrical impulses to interrupt pain signals for patients with intractable chronic nerve pain. The system consists of an implanted microstimulator, a separate electrode array, and an externally worn, battery-free therapy disc, offered as a drug-free treatment option to patients through their doctors.
Founders & leadership
EF
Earl FenderinPresident & CEOEarl Fender has over 30 years of medical technology leadership experience, including roles as President & CEO of Vertiflex (a chronic pain company acquired by Boston Scientific in 2019) and CEO of DePuy Spine, a Johnson & Johnson subsidiary. He holds a B.A. in Business Administration from Thiel College and completed Harvard Business School's Program for Management Development.
LH
Lee HartleyinFounder & CTO2014–2025Lee Hartley is an executive with experience leading technology, R&D, and operations teams in neuromodulation and implantable medical devices, including work in spinal cord and peripheral nerve stimulation. He holds a PhD in Electrical Engineering and has prior experience designing analog and mixed-signal IC systems at IBM.
AM
Allen MeachaminChief Revenue Officer2020–2025President and Chief Executive Officer at Stimdia Medical
BS
Bick SellersinExecutiveBick Sellers is an executive with experience leading operations across medical device, biotech, and technology companies, ranging from Fortune 100 corporations to early-stage startups. His background includes building human resources functions, managing large global teams, and overseeing business integration and IPO preparation.
TA
Thomas A. WestinPresident and CEOThomas A. West is President and CEO of Nalu Medical, a neurostimulation device company developing non-integrated systems for chronic pain management. He previously held leadership positions at Intersect ENT.
JS
Jeffrey SwieckiExecutive
JR
Jonathan RuaisExecutive
Board
VT
Victor TongBoard director
ES
Eric SnyderBoard director
JB
HH
Hugo HarrodBoard director
KH
Keegan HarperBoard director
Investors · 8
.jpeg){kind=logo}
Reported raises · per SEC filings
Form D private placements$127M disclosed across 2 rounds · 2015–2023
▶$115.1MraisedOct 2024 · 29 investors · Other Health CareRule 506(b)
▶$115.1MraisedOct 2024 · 29 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Lee HartleyExecutive Officer
- Victor TongDirector
- Eric SnyderDirector
- Allen MeachamExecutive Officer
- Juliet BakkerDirector
- Hugo HarrodDirector
- Bick SellersExecutive Officer
- Thomas A. WestExecutive Officer, Director
- Keegan HarperDirector
- Robert MittendorffDirector
- Jeffrey SwieckiExecutive Officer
- Jonathan RuaisExecutive Officer
- Geoff PardoDirector
- Alexander AuWerterDirector
- William BurkeDirector
- Offering amount
- $115.1M
- Amount sold
- $115.1M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.9MraisedJul 2015 · 10 investors · Other Health CareRule 506(b)
▶$11.9MraisedJul 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Shahzad MalikDirector
- Keegan HarperExecutive Officer, Director
- Scott MuranoExecutive Officer
- Michael J. PartschExecutive Officer, Director
- Juliet BakkerDirector
- Offering amount
- $28.8M
- Amount sold
- $11.9M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Boston Scientific61 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
MD Anderson Cancer Center50 shared keywordsUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.
Rf Surgical33 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies competing with Nalu for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Street Bikers United Maui Chapter raises $3,700 for Pacific Cancer Foundation’s Children’s Fund | News, Sports, Jobs - Maui Newsmauinews.com · Jul 2026Frequently asked questions
- What does Nalu do?
- Nalu Medical develops a non-integrated neurostimulation system that uses electrical impulses to interrupt pain signals for patients with intractable chronic nerve pain. The system consists of an implanted microstimulator, a separate electrode array, and an externally worn, battery-free therapy disc, offered as a drug-free treatment option to patients through their doctors.
- Who are Nalu's investors?
- Nalu's investors include APERTURE Venture Partners, B Capital Group, B4 Capital, Decheng Capital, Endeavour Vision, Longitude Capital, Runway Growth Capital, Advent Life Sciences.
- How much funding has Nalu raised?
- Nalu has disclosed $127M raised across 2 rounds.
- Where is Nalu headquartered?
- Nalu is headquartered in Carlsbad, US.